DMT Ovariectomy and Butyrate-Enhanced CTA 3

Test of role of ovarian hormones in butyrate-enhanced CTA. Continuation of DMP Ovariectomy and Butyrate-Enhanced CTA.

Dose of NaB based on Kwon and Houpt, Brain Research, 1333 (2010) 36–47, PMID: 20346924 PMCID: PMC2871962

• 0.3 M Na Butyrate = 3.3g/100ml water
• 0.3 M NaCl = 18g/liter water (osmotic control)

Data

Raw Data Link

People

Durba Mukherjee

Agenda

Rats arrive (?????) Female Sprague Dawley rats n=8 (dob ????? ), arrived

Surgery

all rats: ovariectomized + 3mg pellet of 17-beta-estradiol (Innovative Research, Sarasota, FL)

• DMT 1-4 : Surgery on 2022-1-18
• DMT 5-8 : Surgery on 2022-1-19

Carpofen 0.5 mg/kg pre-op, isoflurane and bupivicaine intra-op, carpofen 0.5 mg/kg post-op (next day). Staples removed 7 days post-op.

Day 0: Water removed 2022-1-27

Days 1-8: Water Restriction 2022-1-28 thru 2022-2-4

Weigh rats daily. Water for 10 min, ad lib food.

10 min water at 1400 daily.

Day 9: Conditioning Day 2022-2-8

• 0-30 min: saccharin 0.125%

• at 30 min: 3 ml/kg of 0.15M LiCl ip (all rats)

• at 40 min: 12 ml/kg of 0.3M NaButyrate or NaCl

ad lib water returned after final injection overnight.

Groups:

• OVX + E + LiCl + NaCl: DMT 2,3,4,6
• OVX + E + LiCl + Butyrate: DMT 1,5,7,8

Days 10 - 19: Preference Tests: 2022-2-7 to 2022-2-16

Rats CTA acquisition and extinction was measured with 24-h, 2-bottle preference tests (for ???? days). Rats were given 24-h free access to both 0.125% saccharin and water bottles, alternating position for 10 days.